Cycloset and Hypoglycaemia aggravated - a phase IV clinical study of FDA data
Hypoglycaemia aggravated is found among people who take Cycloset, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Cycloset and have Hypoglycaemia aggravated. It is created by eHealthMe based on reports of 126 people who have side effects when taking Cycloset from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
126 people reported to have side effects when taking Cycloset.
Among them, 7 people (5.56%) have Hypoglycaemia aggravated.
What is Cycloset?
Cycloset has active ingredients of bromocriptine mesylate. It is often used in type 2 diabetes. eHealthMe is studying from 132 Cycloset users for its effectiveness, alternative drugs and more.
What is Hypoglycaemia aggravated?
Hypoglycaemia aggravated (deficiency of glucose in the bloodstream) is found to be associated with 1,399 drugs and 391 conditions by eHealthMe.
Number of Cycloset and Hypoglycaemia aggravated reports submitted per year:
Time on Cycloset when people have Hypoglycaemia aggravated *:
Gender of people who have Hypoglycaemia aggravated when taking Cycloset*:
Age of people who have Hypoglycaemia aggravated when taking Cycloset *:
Common drugs people take besides Cycloset *:
Common side effects people have besides Hypoglycaemia aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Cycloset and have Hypoglycaemia aggravated?Check whether Hypoglycaemia aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Hypoglycaemia aggravated and when was it recovered:
Expand to all the drugs that have ingredients of bromocriptine mesylate:
Alternative drugs to, pros and cons of Cycloset:
- Cycloset (132 reports)
Hypoglycaemia aggravated treatments and more:
- Hypoglycaemia aggravated (12 reports)
COVID vaccines that are related to Hypoglycaemia aggravated:
- Hypoglycaemia aggravated in Moderna COVID Vaccine
- Hypoglycaemia aggravated in Pfizer BioNTech Covid Vaccine
- Hypoglycaemia aggravated in Johnson and Johnson Covid Vaccine
Common drugs associated with Hypoglycaemia aggravated:
- Metformin: 8,926 reports
- Lantus: 7,019 reports
- Humalog: 4,223 reports
- Aspirin: 3,164 reports
- Lasix: 2,489 reports
- Furosemide: 2,241 reports
- Novorapid: 1,962 reports
- Simvastatin: 1,865 reports
- Amlodipine: 1,836 reports
- Amaryl: 1,831 reports
All the drugs that are associated with Hypoglycaemia aggravated:
- Hypoglycaemia aggravated (1,399 drugs)
Common conditions associated with Hypoglycaemia aggravated:
- Type 2 diabetes: 8,956 reports
- Diabetes: 7,378 reports
- High blood pressure: 3,912 reports
- Depression: 1,272 reports
- Pain: 1,021 reports
- High blood cholesterol: 937 reports
All the conditions that are associated with Hypoglycaemia aggravated:
- Hypoglycaemia aggravated (391 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on bromocriptine mesylate (the active ingredients of Cycloset) and Cycloset (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vistaril and Blister - 4 seconds ago
- Vistaril and Feeling Cold - 8 seconds ago
- Tretinoin and Ventricular Tachycardia - 13 seconds ago
- Vistaril and Sepsis - 13 seconds ago
- Nebivolol Hydrochloride and Purpura - 13 seconds ago
- Prevacid and Pulmonary Function Test Nos Decreased - 17 seconds ago
- Dexamethasone and Rectal Prolapse - 17 seconds ago
- Vistaril and Type 2 Diabetes - 17 seconds ago
- Vistaril and Diabetes Mellitus Non-Insulin-Dependent - 17 seconds ago
- Dexamethasone Acetate and Tramadol drug interaction - 21 seconds ago